Journal profile · BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
Drug Testing and Analysis
ISSN 1942-7603 · eISSN 1942-7611 · John Wiley and Sons Ltd · ENGLAND · Bimonthly · Founded 2009
Drug Testing and Analysis: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.56; hybrid open access; APC about USD 4,440; median 85 days to acceptance (92 articles, last 24 months); community-reported acceptance: about 75%; 170 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Drug Testing and Analysis is published by John Wiley and Sons Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Forensic Toxicology and Drug Analysis, Hormonal and reproductive studies and Psychedelics and Drug Studies, together about 37.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Drug Testing and Analysis (DTA) is devoted to the publication of papers dealing with the development and application of techniques for the determination of controlled or controversial substances.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
Editor-in-chief Mario ThevisPublisher website
Editorial board by country: none in mainland China; most named Germany 10, United Kingdom 7, United States 2, France 2, Netherlands 2 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics18%
- Hormonal and reproductive studiesMedicine13.9%
- Psychedelics and Drug StudiesPsychology5.8%
- Muscle metabolism and nutritionBiochemistry, Genetics and Molecular Biology5.7%
- Cannabis and Cannabinoid ResearchMedicine5.7%
- Mass Spectrometry Techniques and ApplicationsChemistry4.2%
- Pharmacological Effects and AssaysAgricultural and Biological Sciences4.2%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
| Minor | Chemistry, Analytical | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
| Minor | Chemistry, Analytical | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 2 |
| Minor | Chemistry, Analytical | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.56LetPub ·
- Impact factor (publisher)
- 2.6Publisher website ·
- Impact factor (publisher) 2025
- 2.6Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- CiteScore (publisher)
- 5.4Publisher website ·
- CiteScore (publisher) 2025
- 5.4Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 44LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 1,624OpenAlex ·
- 2-year mean citedness
- 2.78OpenAlex ·
- Self-citation rate
- 19.2%LetPub ·
- Share of gold OA articles
- 43.78%LetPub ·
Volume
- Articles per year
- 124LetPub ·
- Articles per year (publisher) 2025
- 133Publisher website ·
- Downloads per year (publisher) 2025
- 558,220Publisher website ·
Articles by year OpenAlex count · 3,287 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 144 | 85 | 50 |
| 2025 | 170 | 109 | 397 |
| 2024 | 227 | 143 | 1,059 |
| 2023 | 204 | 144 | 1,499 |
| 2022 | 218 | 95 | 2,348 |
| 2021 | 213 | 83 | 2,753 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
85 daysMedian, submission to acceptance · P25–P75 53 days – 133 days
- Acceptance to online
- median 15 days (92 articles)
- Submission to online
- median 103 days
- Sample
- 92 articles with submission and acceptance dates (334 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Acceptance rate (publisher)
- 32%Publisher website ·
- Acceptance rate (publisher) 2025
- 32%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 89 daysPublisher website ·
- Acceptance to publication 2025
- 11 daysPublisher website ·
- Peer review
- Double-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,440 / EUR 3,690 / GBP 2,970 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
- Cover letter
- Optional
- Not considered
- double-line spacing
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright
- Authorship Authorship
On initial submission, the submitting author will be prompted to provide the email address and country for all contributing authors.
Source ↗Publisher website ·- Data availability Encourages Data Sharing
DTA encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper. Visit re3data.org or fairsharing.org to help identify registered and certif…
Source ↗Publisher website ·- License & copyright Copyright and Permissions
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. For authors signing the copyright transfer agreement If the OnlineOpen option is not select…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2009
- ISSN
- 1942-7603
- Electronic ISSN
- 1942-7611
- Latest issue on the website
- Volume 18, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Drug Testing and Analysis
What CAS zone is Drug Testing and Analysis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drug Testing and Analysis is in Zone 3 of Medicine, and in Zone 3 of the minor category Biochemical Research Methods / Chemistry, Analytical / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drug Testing and Analysis?
The latest impact factor listed by LetPub is 2.56; CiteScore 5.4, h-index 82.
How long does peer review take at Drug Testing and Analysis?
Based on the dates recorded on 92 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 85 days (interquartile range 53–133 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”; the journal's website gives an acceptance rate of 32% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Drug Testing and Analysis?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Graphical abstract: Required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Drug Testing and Analysis based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (10), United Kingdom (7) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Drug Testing and Analysis?
According to LetPub and DOAJ records, Drug Testing and Analysis is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Drug Testing and Analysis open access, and what is the APC?
Drug Testing and Analysis is a hybrid journal. For open-access publication: APC about USD 4,440.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .